Income Statement cbdMD, Inc.

Equities

YCBD

US12482W4087

Pharmaceuticals

Delayed Nyse Other stock markets 12:49:15 2025-12-05 pm EST			5-day change	1st Jan Change
0.6120 ^USD	+0.10%		-0.97%	-79.60%

Nov. 21	CbdMD reports preliminary unaudited fourth quarter results	RE
Nov. 21	CbdMD, Inc. Reports Preliminary Earnings Results for the Fourth Quarter and Year Ended September 30, 2025	CI

23dfb513d7cf11cd4ed32049.d7JT-ZEDEipT_LtaMamw4xHu-LuOc12oC7euc64tSGQ.GdoqzqZKSlkDltJ3Y-jSsXO4iYrGGG__U5rZKddvKR5H4DrU3nokTh-lgw

Published financial data: CBDMD, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2020	2021	2022	2023	2024
Revenues	41.88M	44.48M	35.4M	24.16M	19.48M
Total Revenues	41.88M	44.48M	35.4M	24.16M	19.48M
Cost of Goods Sold, Total	15.51M	14.5M	13.07M	9.18M	7.49M
Gross Profit	26.37M	29.99M	22.34M	14.98M	12M
Selling General & Admin Expenses, Total	41.27M	44.92M	39.65M	17.36M	13.27M
R&D Expenses	1.16M	1.42M	-	173K	39.02K
Depreciation & Amortization - (IS)	-	1.02M	-	404K	452K
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	1.4M	698K
Other Operating Expenses	1.04M	2.24M	-	4.91M	857K
Other Operating Expenses, Total	43.46M	49.6M	39.65M	24.25M	15.31M
Operating Income	-17.09M	-19.62M	-17.31M	-9.27M	-3.32M
Interest Expense, Total	-	-28.93K	-	-	-29.51K
Interest And Investment Income	39.88K	-	-	63.7K	-
Net Interest Expenses	39.88K	-28.93K	-	63.7K	-29.51K
Other Non Operating Income (Expenses)	-1	29.48K	255K	-	-
EBT, Excl. Unusual Items	-17.05M	-19.62M	-17.06M	-9.2M	-3.34M
Restructuring Charges	-	-	-602K	-	-
Impairment of Goodwill	-	-	-60.96M	-	-
Gain (Loss) On Sale Of Investments	-932K	547K	-33.35K	-700K	-
Gain (Loss) On Sale Of Assets	-	-	88.77K	-	-
Asset Writedown	-	-	-	-13.22M	-
Other Unusual Items	29.29M	-5.22M	8.47M	186K	-355K
EBT, Incl. Unusual Items	11.31M	-24.29M	-70.08M	-22.94M	-3.7M
Income Tax Expense	-1.35M	-895K	-	-	-
Earnings From Continuing Operations	12.65M	-23.39M	-70.08M	-22.94M	-3.7M
Earnings Of Discontinued Operations	-48.98K	-	-	-	-
Net Income to Company	12.6M	-23.39M	-70.08M	-22.94M	-3.7M
Minority Interest	-	-	-	-	-
Net Income - (IS)	12.6M	-23.39M	-70.08M	-22.94M	-3.7M
Preferred Dividend and Other Adjustments	367K	2.55M	4M	4M	4M
Net Income to Common Incl Extra Items	12.24M	-25.95M	-74.09M	-26.94M	-7.7M
Net Income to Common Excl. Extra Items	12.28M	-25.95M	-74.09M	-26.94M	-7.7M
Per Share Items
Net EPS - Basic	99.79	-170.04	-446.37	-106.57	-14.29
Basic EPS - Continuing Operations	100.19	-170.04	-446.37	-106.57	-14.29
Basic Weighted Average Shares Outstanding	123K	153K	166K	253K	539K
Net EPS - Diluted	99.79	-170.04	-446.4	-106.57	-14.32
Diluted EPS - Continuing Operations	100.19	-170.04	-446.4	-106.57	-14.32
Diluted Weighted Average Shares Outstanding	125K	153K	166K	253K	539K
Normalized Basic EPS	-86.92	-80.34	-64.22	-22.76	-3.88
Normalized Diluted EPS	-84.94	-80.34	-64.22	-22.76	-3.88
Payout Ratio	2.91	-10.92	-5.71	-15.99	-
Supplemental Items
EBITDA	-16.37M	-18.6M	-15.48M	-7.47M	-2.17M
EBITA	-17.09M	-19.57M	-16.43M	-7.87M	-2.62M
EBIT	-17.09M	-19.62M	-17.31M	-9.27M	-3.32M
EBITDAR	-14.83M	-17.05M	-14.09M	-6.14M	512K
Total Revenues (As Reported)	41.88M	44.48M	35.4M	24.16M	19.48M
Effective Tax Rate - (Ratio)	-11.9	3.68	-	-	-
Deferred Domestic Taxes	-1.35M	-895K	-	-	-
Total Deferred Taxes	-1.35M	-895K	-	-	-
Normalized Net Income	-10.66M	-12.26M	-10.66M	-5.75M	-2.09M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	14.92M	17.9M	15.36M	5.98M	4.18M
Selling and Marketing Expenses	16.82M	19.64M	-	6.95M	4.18M
General and Administrative Expenses	5.11M	4.36M	-	2.62M	2.17M
Research And Development Expense From Footnotes	1.16M	1.42M	-	173K	39.02K
Net Rental Expense, Total	1.54M	1.55M	1.39M	1.33M	2.68M
Imputed Operating Lease Interest Expense	-	48.54K	-	-	255K
Imputed Operating Lease Depreciation	-	1.5M	-	-	2.42M
Stock-Based Comp., SG&A Exp. (Total)	1.99M	3.15M	-	349K	43.69K
Stock-Based Comp., Other (Total)	391K	97.72K	-	885K	-
Total Stock-Based Compensation	2.38M	3.25M	-	1.23M	43.69K

Fiscal Period: September	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	14.82M	26.41M	6.72M	1.8M	2.45M
Short Term Investments	317K	1.03M	1M	-	-
Total Cash And Short Term Investments	15.14M	27.44M	7.72M	1.8M	2.45M
Accounts Receivable, Total	911K	1.11M	1.45M	1.22M	984K
Other Receivables	-	-	-	-	-
Total Receivables	911K	1.11M	1.45M	1.22M	984K
Inventory	4.89M	5.57M	4.77M	4.24M	2.52M
Prepaid Expenses	903K	1.15M	702K	750K	407K
Other Current Assets, Total	1.86M	1.22M	1.37M	70.06K	21.75K
Total Current Assets	23.71M	36.5M	16.01M	8.07M	6.39M
Gross Property Plant And Equipment	10.95M	10.04M	6.36M	5.53M	2.44M
Accumulated Depreciation	-913K	-1.86M	-1.05M	-1.46M	-1.9M
Net Property Plant And Equipment	10.03M	8.18M	5.3M	4.07M	540K
Long-term Investments	-	-	1.4M	700K	700K
Goodwill	54.67M	56.67M	-	-	-
Other Intangibles, Total	21.64M	23M	17.83M	3.22M	2.89M
Other Long-Term Assets, Total	791K	530K	245K	139K	62.71K
Total Assets	111M	125M	40.79M	16.2M	10.58M
Liabilities
Accounts Payable, Total	2.85M	2.98M	2.04M	1.91M	1.54M
Accrued Expenses, Total	2.72M	2.73M	2.06M	1.48M	633K
Short-term Borrowings	55.64K	59.47K	9.61K	2.49K	1.17M
Current Portion of Long-Term Debt	854K	-	-	-	-
Current Portion of Leases	1.16M	1.15M	1.18M	1.28M	98.7K
Unearned Revenue Current, Total	45.14K	-	-	-	503K
Other Current Liabilities	-	-	-	-	4.67M
Total Current Liabilities	7.69M	6.92M	5.29M	4.67M	8.62M
Long-Term Debt	749K	-	3K	-	-
Long-Term Leases	6.01M	4.86M	3.68M	2.4M	-
Deferred Tax Liability Non Current	895K	-	-	-	-
Other Non Current Liabilities	16.32M	9.96M	398K	90.37K	-
Total Liabilities	31.66M	21.74M	9.37M	7.16M	8.62M
Preferred Stock Convertible	500	5K	5K	5K	5K
Total Preferred Equity	500	5K	5K	5K	5K
Common Stock, Total	52.13K	57.78K	60.67K	2.96K	3.94K
Additional Paid In Capital	127M	176M	179M	183M	184M
Retained Earnings	-47.39M	-73.34M	-147M	-174M	-182M
Comprehensive Income and Other	-	-	-	-	-7.19K
Total Common Equity	79.18M	103M	31.42M	9.03M	1.96M
Total Equity	79.18M	103M	31.42M	9.03M	1.96M
Total Liabilities And Equity	111M	125M	40.79M	16.2M	10.58M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	145K	161K	169K	370K	692K
ECS Total Common Shares Outstanding	145K	161K	169K	370K	492K
Book Value / Share	546.8	642.56	186.45	24.39	3.98
Tangible Book Value	2.88M	23.46M	13.58M	5.81M	-931K
Tangible Book Value Per Share	19.86	146.17	80.61	15.69	-1.89
Total Debt	8.83M	6.07M	4.87M	3.68M	1.27M
Net Debt	-6.31M	-21.38M	-2.85M	1.89M	-1.18M
Debt Equivalent Oper. Leases	12.32M	12.38M	11.13M	10.63M	21.42M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	2.71M	3.36M	3.2M	2.78M	1.53M
Inventories - Others	1.98M	1.73M	1.21M	1.4M	830K
Machinery, Total	3.26M	3.55M	1.39M	1.69M	1.87M
Full Time Employees	165	154	90	52	42
Accumulated Allowance for Doubtful Accounts (Supple)	20.66K	3.63K	36.98K	42.18K	346K

Fiscal Period: September	2020	2021	2022	2023	2024
Net Income	12.6M	-23.39M	-70.08M	-22.94M	-3.7M
Depreciation & Amortization - CF	721K	2.21M	2.09M	1.53M	1.12M
Amortization of Goodwill and Intangible Assets - (CF)	-	48.48K	884K	1.4M	698K
Depreciation & Amortization, Total	721K	2.25M	2.97M	2.93M	1.82M
(Gain) Loss From Sale Of Asset	-	-	-322K	-	-
(Gain) Loss on Sale of Investments - (CF)	932K	325K	941K	700K	-
Asset Writedown & Restructuring Costs	-	-	60.96M	13.22M	-
Stock-Based Compensation (CF)	2.38M	3.02M	929K	343K	16.9K
Net Cash From Discontinued Operations	633K	436K	9.59K	1.38K	-
Other Operating Activities, Total	-27.74M	6.09M	-7.6M	875K	1.97M
Change In Accounts Receivable	514K	-184K	65.54K	278K	232K
Change In Inventories	80.13K	-1.27M	-72.13K	356K	790K
Change In Accounts Payable	1.48M	-104K	-1.81M	-1.29M	-1.12M
Change in Unearned Revenues	37.8K	3.72K	203K	203K	318K
Change In Deferred Taxes	-1.35M	-895K	-	-	-
Change in Other Net Operating Assets	-951K	-372K	-1.16M	1.02M	-679K
Cash from Operations	-10.66M	-14.09M	-14.97M	-4.3M	-353K
Capital Expenditure	-1.32M	-342K	-689K	-298K	-190K
Cash Acquisitions	-	-2M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-100K
Investment in Marketable and Equity Securities, Total	-250K	-210K	-	1M	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-1.57M	-2.55M	-689K	702K	-290K
Short Term Debt Issued, Total	29.63K	-	-	-	1.25M
Long-Term Debt Issued, Total	1.46M	-	-	-	-
Total Debt Issued	1.49M	-	-	-	1.25M
Short Term Debt Repaid, Total	-	-152K	-33.36K	-133K	-
Total Debt Repaid	-	-152K	-33.36K	-133K	-
Issuance of Common Stock	16.77M	-	-	2.48M	50K
Issuance of Preferred Stock	4.42M	30.94M	-	-	-
Preferred Dividends Paid	-367K	-2.55M	-4M	-3.67M	-
Common & Preferred Stock Dividends Paid	-367K	-2.55M	-4M	-3.67M	-
Other Financing Activities, Total	62.2K	-	-	-	-
Cash from Financing	22.37M	28.23M	-4.04M	-1.32M	1.3M
Miscellaneous Cash Flow Adjustments	-1	-	-	-	-
Net Change in Cash	10.13M	11.59M	-19.69M	-4.92M	655K
Supplemental Items
Cash Interest Paid	33.69K	28.93K	2.36K	6.4K	74.64K
Levered Free Cash Flow	-5.32M	-7.48M	-9.38M	-616K	5.78M
Unlevered Free Cash Flow	-5.32M	-7.46M	-9.38M	-616K	5.79M
Change In Net Working Capital	-3.59M	360K	843K	-1.31M	-6.29M
Net Debt Issued / Repaid	1.49M	-152K	-33.36K	-133K	1.25M

Fiscal Period: September	2020	2021	2022	2023	2024
Profitability
Return on Assets	-10.4	-10.4	-13.06	-20.33	-15.48
Return on Total Capital	-16.98	-12.44	-14.87	-23.64	-25.99
Return On Equity %	21.67	-25.66	-104.16	-113.4	-67.31
Return on Common Equity	21.04	-28.47	-110.12	-133.22	-140.27
Margin Analysis
Gross Profit Margin %	62.96	67.41	63.09	62.01	61.57
SG&A Margin	98.53	100.99	111.99	71.89	68.09
EBITDA Margin %	-39.09	-41.81	-43.72	-30.92	-11.12
EBITA Margin %	-40.81	-43.99	-46.4	-32.59	-13.44
EBIT Margin %	-40.81	-44.1	-48.9	-38.37	-17.02
Income From Continuing Operations Margin %	30.21	-52.6	-197.96	-94.96	-18.99
Net Income Margin %	30.09	-52.6	-197.96	-94.96	-18.99
Net Avail. For Common Margin %	29.33	-58.34	-209.26	-111.53	-39.54
Normalized Net Income Margin	-25.45	-27.56	-30.11	-23.82	-10.73
Levered Free Cash Flow Margin	-12.7	-16.81	-26.5	-2.55	29.65
Unlevered Free Cash Flow Margin	-12.7	-16.77	-26.5	-2.55	29.74
Asset Turnover
Asset Turnover	0.41	0.38	0.43	0.85	1.46
Fixed Assets Turnover	7.13	4.88	5.25	5.16	8.46
Receivables Turnover (Average Receivables)	35.84	43.93	27.65	18.14	17.71
Inventory Turnover (Average Inventory)	3.07	2.77	2.53	2.04	2.22
Short Term Liquidity
Current Ratio	3.08	5.28	3.03	1.73	0.74
Quick Ratio	2.09	4.13	1.73	0.65	0.4
Operating Cash Flow to Current Liabilities	-1.39	-2.04	-2.83	-0.92	-0.04
Days Sales Outstanding (Average Receivables)	10.21	8.31	13.2	20.13	20.66
Days Outstanding Inventory (Average Inventory)	119.09	131.76	144.43	179.03	165.23
Average Days Payable Outstanding	70.69	70.1	74.66	83.23	109.24
Cash Conversion Cycle (Average Days)	58.62	69.97	82.98	115.93	76.66
Long Term Solvency
Total Debt/Equity	11.15	5.88	15.5	40.78	64.68
Total Debt / Total Capital	10.03	5.56	13.42	28.97	39.28
LT Debt/Equity	8.54	4.71	11.72	26.61	-
Long-Term Debt / Total Capital	7.68	4.45	10.15	18.9	-
Total Liabilities / Total Assets	28.56	17.41	22.96	44.24	81.44
EBIT / Interest Expense	-	-678.05	-	-	-112.36
EBITDA / Interest Expense	-	-589.4	-	-	17.36
(EBITDA - Capex) / Interest Expense	-	-601.23	-	-	10.92
Total Debt / EBITDA	-0.6	-0.36	-0.35	-0.6	2.48
Net Debt / EBITDA	0.43	1.25	0.2	-0.31	-2.31
Total Debt / (EBITDA - Capex)	-0.55	-0.35	-0.33	-0.57	3.94
Net Debt / (EBITDA - Capex)	0.39	1.23	0.19	-0.29	-3.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	77.09	6.2	-20.41	-31.77	-19.35
Gross Profit, 1 Yr. Growth %	81.67	13.72	-25.51	-32.95	-19.91
EBITDA, 1 Yr. Growth %	16.17	10.3	-16.78	-51.75	-71
EBITA, 1 Yr. Growth %	19.69	11.29	-16.26	-52.08	-66.74
EBIT, 1 Yr. Growth %	19.03	11.57	-11.75	-46.46	-64.23
Earnings From Cont. Operations, 1 Yr. Growth %	-127.85	-284.92	199.57	-67.27	-83.87
Net Income, 1 Yr. Growth %	-124.99	-285.64	199.57	-67.27	-83.87
Normalized Net Income, 1 Yr. Growth %	19.37	11.82	-13.05	-46.03	-63.66
Diluted EPS Before Extra, 1 Yr. Growth %	-110.96	-269.72	162.52	-76.13	-86.56
Accounts Receivable, 1 Yr. Growth %	-36.07	22.15	30.04	-16.01	-19.09
Inventory, 1 Yr. Growth %	-6.02	13.94	-14.46	-11.15	-40.41
Net Property, Plant and Equip., 1 Yr. Growth %	484.93	-18.52	-35.17	-23.27	-86.72
Total Assets, 1 Yr. Growth %	17.27	12.67	-67.34	-60.3	-34.66
Tangible Book Value, 1 Yr. Growth %	-107.43	715.64	-42.1	-57.25	-116.03
Common Equity, 1 Yr. Growth %	110.57	30.25	-69.54	-71.27	-78.3
Cash From Operations, 1 Yr. Growth %	-30.65	32.15	6.2	-71.26	-91.8
Capital Expenditures, 1 Yr. Growth %	10.13	-74.09	101.36	-56.79	-36.14
Levered Free Cash Flow, 1 Yr. Growth %	-42.12	66.79	25.42	-92.54	-484.89
Unlevered Free Cash Flow, 1 Yr. Growth %	-42.12	66.39	25.72	-92.54	-486.12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	855.15	37.14	-8.06	-26.31	-25.82
Gross Profit, 2 Yr. CAGR %	761.75	43.73	-7.96	-29.33	-26.72
EBITDA, 2 Yr. CAGR %	219.43	14.88	-4.19	-36.63	-62.59
EBITA, 2 Yr. CAGR %	225.75	17.05	-3.34	-36.65	-60.08
EBIT, 2 Yr. CAGR %	208.4	16.88	-0.77	-31.26	-56.24
Earnings From Cont. Operations, 2 Yr. CAGR %	165.33	-28.24	135.36	-0.98	-77.02
Net Income, 2 Yr. CAGR %	453.01	-31.89	135.82	-0.98	-77.02
Normalized Net Income, 2 Yr. CAGR %	208.04	17.18	-1.4	-31.5	-55.71
Diluted EPS Before Extra, 2 Yr. CAGR %	9.5	-56.87	111.08	-20.83	-82.09
Accounts Receivable, 2 Yr. CAGR %	-29.73	-11.63	26.03	4.51	-17.56
Inventory, 2 Yr. CAGR %	-	3.48	-1.28	-12.82	-27.24
Net Property, Plant and Equip., 2 Yr. CAGR %	4.57K	118.31	-27.32	-29.47	-68.08
Total Assets, 2 Yr. CAGR %	171.68	14.95	-39.34	-63.99	-49.07
Tangible Book Value, 2 Yr. CAGR %	-51.44	-22.14	117.32	-50.25	-73.82
Common Equity, 2 Yr. CAGR %	150.61	65.61	-37.01	-70.42	-75.03
Cash From Operations, 2 Yr. CAGR %	38.33	-4.27	18.47	-44.75	-84.65
Capital Expenditures, 2 Yr. CAGR %	648.56	-46.58	-27.77	-6.73	-47.47
Levered Free Cash Flow, 2 Yr. CAGR %	-	-9.78	44.63	-71.31	-16.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-9.89	44.63	-71.27	-16.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	359.29	14.39	-16.76	-24.06
Gross Profit, 3 Yr. CAGR %	-	338.73	15.45	-17.18	-26.32
EBITDA, 3 Yr. CAGR %	-	126.31	3.17	-23.77	-51.17
EBITA, 3 Yr. CAGR %	-	129.88	4.78	-23.5	-48.9
EBIT, 3 Yr. CAGR %	-	121.83	6.43	-19.22	-44.71
Earnings From Cont. Operations, 3 Yr. CAGR %	-	135.24	15.55	21.94	-45.92
Net Income, 3 Yr. CAGR %	-	284.34	11.6	22.1	-45.92
Normalized Net Income, 3 Yr. CAGR %	-	121.83	6.09	-19.34	-44.55
Diluted EPS Before Extra, 3 Yr. CAGR %	-	26.72	-21.26	2.08	-56.17
Accounts Receivable, 3 Yr. CAGR %	-	-15.51	0.51	10.09	-4.04
Inventory, 3 Yr. CAGR %	-	-	-2.89	-4.69	-23.2
Net Property, Plant and Equip., 3 Yr. CAGR %	-	1.11K	45.65	-25.99	-59.58
Total Assets, 3 Yr. CAGR %	-	102.6	-24.43	-47.33	-56.08
Tangible Book Value, 3 Yr. CAGR %	-	24.37	-29.46	26.39	-65.89
Common Equity, 3 Yr. CAGR %	-	101.5	-5.81	-51.51	-73.32
Cash From Operations, 3 Yr. CAGR %	-	36.24	-0.9	-26.11	-70.75
Capital Expenditures, 3 Yr. CAGR %	-	143.95	-16.87	-39.14	-17.79
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	0.69	-48.41	-8.25
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	0.69	-48.41	-8.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	120.91	-3.8
Gross Profit, 5 Yr. CAGR %	-	-	-	111.36	-3.74
EBITDA, 5 Yr. CAGR %	-	-	-	36.01	-31.24
EBITA, 5 Yr. CAGR %	-	-	-	37.34	-28.77
EBIT, 5 Yr. CAGR %	-	-	-	38.83	-25.41
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	66.42	-39.44
Net Income, 5 Yr. CAGR %	-	-	-	123.42	-40.69
Normalized Net Income, 5 Yr. CAGR %	-	-	-	38.64	-25.2
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	4.99	-56.45
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-8.01	-7.15
Inventory, 5 Yr. CAGR %	-	-	-	-	-13.48
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	288.33	-20.64
Total Assets, 5 Yr. CAGR %	-	-	-	1.52	-35.46
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-13.79	-52.55
Common Equity, 5 Yr. CAGR %	-	-	-	-6.46	-44.62
Cash From Operations, 5 Yr. CAGR %	-	-	-	-5.05	-53
Capital Expenditures, 5 Yr. CAGR %	-	-	-	66.07	-30.81
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-8.87
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-8.81